cdr3.alpha	v.alpha	j.alpha	cdr3.beta	v.beta	d.beta	j.beta	species	mhc.a	mhc.b	mhc.class	antigen.epitope	antigen.gene	antigen.species	reference.id	submitter	method.identification	method.frequency	method.singlecell	method.sequencing	method.verification	meta.study.id	meta.cell.subset	meta.subset.frequency	meta.subject.cohort	meta.subject.id	meta.replica.id	meta.clone.id	meta.epitope.id	meta.tissue	meta.donor.MHC	meta.donor.MHC.method	meta.structure.id	comment
																																	
																																	
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*0201	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.085	healthy	001				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*0201	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.07	healthy	002				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSPLFGTSGGETYYFG	TRBV6-5		TRBJ2.5	HomoSapiens	HLA-A*0201	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.07	healthy	002				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*0201	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.024	healthy	004				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSPQTGASYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*0201	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.024	healthy	004				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSLVGGRYGYTFG	TRBV12-3		TRBJ1.2	HomoSapiens	HLA-A*0201	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.024	healthy	004				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV8
			CASSLGBGRGGYTFG	TRBV12-3		TRBJ1.2	HomoSapiens	HLA-A*0201	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.024	healthy	004				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV8
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*0201	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.017	healthy	005				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSPATGTIYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*0201	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.017	healthy	005				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV13.1
			CASSLTSGSPDTQYFG	TRBV27		TRBJ2.3	HomoSapiens	HLA-A*0201	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.017	healthy	005				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV14
			CASSILGVSSYNEQFFG	TRBV7-6		TRBJ2.1	HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.23	healthy	025				PBMC	HLA-A2, HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
			CASSFRDYGRYEQYFG	TRBV7-6		TRBJ2.7	HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.038	healthy	027				PBMC	HLA-A2, HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
			CASSILGISSYNEQFFG	TRBV7-6		TRBJ2.1	HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.036	healthy	029				PBMC	HLA-A2/HLA-A2, HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
			CASSLGPITEAPFG	TRBV27		TRBJ1.1	HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.059	healthy	030				PBMC	HLA-A2, HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV14
			CASSPSAQYNEQFFG	TRBV7-6		TRBJ2.1	HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.065	healthy	040				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
			CASSLRGAATDTQYFG	TRBV7-6		TRBJ2.1	HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.065	healthy	040				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
			CASTNHDRGGMNTEAPFG	TRBV7-6		TRBJ1.1	HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.073	healthy	041				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
			CASSLVGQGLSDEQFFG	TRBV7-6		TRBJ2.1	HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.035	healthy	043				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper BV6.4
CATVLRMDSSYKLIFG	TRAV3	TRAJ16.5					HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.23	healthy	025				PBMC	HLA-A2, HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper AV3.1
CAVRVSMDSSYKLIFG	TRAV16	TRAJ16.5					HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.065	healthy	040				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper AV16.1
CAMREGRDSSYKLIFG	TRAV6	TRAJ16.5					HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.073	healthy	041				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper AV6.1
CAVRVSMDSSYKLIFG	TRAV16	TRAJ16.5					HomoSapiens	HLA-B*0702	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin				sanger			CD8	0.073	healthy	041				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. Originally provided in the paper AV16.1
